Bortemap 2mg Injection may cause excessive drowsiness with alcohol.
Bortemap 2mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Bortemap 2mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Bortemap 2mg Injection may cause side effects which could affect your ability to drive.<BR>Bortemap 2mg Injection might cause tiredness, dizziness, fainting, or blurred vision which may affect your ability to drive.
Bortemap 2mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Bortemap 2mg Injection may be needed. Please consult your doctor.<BR>Limited information is available on the use of Bortemap 2mg Injection in these patients.
Bortemap 2mg Injection should be used with caution in patients with liver disease. Dose adjustment of Bortemap 2mg Injection may be needed. Please consult your doctor.
Bortemap 2mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
Yes, Bortemap is approved by FDA
Bortemap is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
Bortemap may cause side effects such as constipation.
Yes, Bortemap is dialyzable
Bortemap can cause toxic effects if not given in appropriate dose although not everybody gets them
Bortemap belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA